[
  {
    "ts": null,
    "headline": "Centene Corp. stock underperforms Tuesday when compared to competitors",
    "summary": "Centene Corp. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=189cc67ca9ceb2f429ef9080fe60e2464e3565834ae0e3effe97e79f70d7cfa7",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732035720,
      "headline": "Centene Corp. stock underperforms Tuesday when compared to competitors",
      "id": 131609832,
      "image": "",
      "related": "CNC",
      "source": "MarketWatch",
      "summary": "Centene Corp. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=189cc67ca9ceb2f429ef9080fe60e2464e3565834ae0e3effe97e79f70d7cfa7"
    }
  },
  {
    "ts": null,
    "headline": "Centene price target lowered to $73 from $90 at Wells Fargo",
    "summary": "Wells Fargo analyst Stephen Baxter lowered the firm’s price target on Centene (CNC) to $73 from $90 and keeps an Overweight rating on the shares as the firm updates Managed Care estimates post-election. All estimates assume the expiration of enhanced exchange subsidies for 2026, Wells notes. The firm believes Medicare Advantage risk/reward improves with Republicans, although areas of concern still exist. Published first on TheFly – the ultimate source for real-time, market-moving breaking financ",
    "url": "https://finnhub.io/api/news?id=359f3b810a78881d5c0970a17b4e623c63dc2b623e465e94e1354facc9e29c45",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732014953,
      "headline": "Centene price target lowered to $73 from $90 at Wells Fargo",
      "id": 131480657,
      "image": "https://media.zenfs.com/en/tipranks_452/2a5eed99ed1798f832251e43ae7eb940",
      "related": "CNC",
      "source": "Yahoo",
      "summary": "Wells Fargo analyst Stephen Baxter lowered the firm’s price target on Centene (CNC) to $73 from $90 and keeps an Overweight rating on the shares as the firm updates Managed Care estimates post-election. All estimates assume the expiration of enhanced exchange subsidies for 2026, Wells notes. The firm believes Medicare Advantage risk/reward improves with Republicans, although areas of concern still exist. Published first on TheFly – the ultimate source for real-time, market-moving breaking financ",
      "url": "https://finnhub.io/api/news?id=359f3b810a78881d5c0970a17b4e623c63dc2b623e465e94e1354facc9e29c45"
    }
  }
]